Willie Quinn

Willie Quinn is currently the President & CEO at Bolt Biotherapeutics, Inc., a company focused on developing pharmaceutical products for cancer treatment. Prior to Bolt Bio, Quinn held leadership roles in various organizations including A Foundation Building Strength, Sunesis Pharmaceuticals, Midnight Pharma, Neurogastrx, Bullet Biotechnology, and Jazz Pharmaceuticals. Quinn has a strong background in finance, business development, and corporate operations. Willie holds an MBA from Stanford University Graduate School of Business, along with multiple degrees in Japanese literature and language.